Xencor Inc(XNCR)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Xencor Inc (XNCR) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores XNCR at 11.6/100 on a 32-signal composite quality model, placing it at rank #2,901 of 2,962 stocks — the bottom half of the AI-ranked universe. Areas of concern include free cash flow (4.4) and revenue growth (5.3), which score below median versus the broader universe. Shareholder dilution risk is elevated at 5.6/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Xencor Inc reports quarterly revenue of $51.2M, net income of $-21.7M, free cash flow of $-56.2M. Top institutional holders of XNCR by reported 13-F value include BlackRock, PRIMECAP MANAGEMENT, BVF, based on the most recent SEC filings. XNCR trades on the Nasdaq exchange and files with the SEC under CIK 1326732. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate XNCR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Xencor Inc directly from SEC EDGAR.